Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JDXL decoction plus metronomic thalidomide for elderly or relapsed/refractory non-Hodgkin lymphoma
ChiCTR1900022510Phase 4Recruiting
- Sponsor
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of thalidomide in non-Hodgkin lymphoma (NHL) (2 arms), sponsored by Shanghai Municipal Hospital of Traditional Chinese Medicine. Primary endpoints: Tumor volume at day 84, Quality of life assessment at day 84 and 2 more. Started Oct 2018; status: recruiting.
02
Drugs
thalidomide
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on ChiCTR1900022510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022510.